Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial
- PMID: 26076022
- PMCID: PMC4468068
- DOI: 10.1371/journal.pone.0130353
Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial
Erratum in
-
Correction: Cognitive Improvement during Treatment for Mild Alzheimer's Disease with a Chinese Herbal Formula: A Randomized Controlled Trial.PLoS One. 2018 Jun 25;13(6):e0199895. doi: 10.1371/journal.pone.0199895. eCollection 2018. PLoS One. 2018. PMID: 29940040 Free PMC article.
Abstract
Objectives: To explore the efficacy of Chinese herbal formula compared with donepezil 5 mg/day in patients with mild Alzheimer's disease (AD).
Methods: Patients with mild AD meeting the criteria were randomized into Chinese herbal formula Yishen Huazhuo decoction (YHD) group and donepezil hydrochloride (DH) group during the 24-week trial. The outcomes were measured by ADAS-cog, MMSE, ADL, and NPI with linear mixed-effect models.
Results: 144 patients were randomized. The mean scores of ADAS-cog and MMSE in both YHD group and DH group both improved at the end of the 24-week treatment period. The results also revealed that YHD was better at improving the mean scores of ADAS-cog and MMSE than DH. Linear mixed-effect models with repeated measures showed statistical significance in time × group interaction effect of ADAS-cog and also in time × group interaction effect of MMSE. The data showed YHD was superior to DH in improving the scores and long term efficacy.
Conclusions: Our study suggests that Chinese herbal formula YHD is beneficial and effective for cognitive improvement in patients with mild AD and the mechanism might be through reducing amyloid-β (Aβ) plaque deposition in the hippocampus.
Trial registration: Chinese Clinical Trial Registry ChiCTR-TRC-12002846.
Conflict of interest statement
Figures
References
-
- Brookmeyer R, Johnson E, Ziegler-Graham K, Arrighi HM. Forecasting the global burden of Alzheimer’s disease. Alzheimer's & dementia, 2007, 3(3): 186–191. - PubMed
-
- Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer J A, Berg S, et al. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry, 2006,63(2):168–74. - PubMed
-
- Hardy J, Allsop D. Amyloid Deposition as the Central Event in the Aetiology of Alzheimer's Disease. Trends in Pharmacological Sciences. 1991,12(10):383–88. - PubMed
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical